Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solriamfetol and CBT-I for Insomnia Disorder
NCT05838430Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2023
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solriamfetol in Insomnia, sponsored by University of Pennsylvania. Started Jul 2023; status: completed.
02
Drugs
solriamfetol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT05838430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05838430.